Follow-up research using your prior genetic testing results
Part of Cancer, Genetic & congenital clinical trials.
This study is for adults who have already had their entire genetic code read as part of certain other research studies. It will use that genetic information to learn more about genes and health, and it requires that you agreed earlier to be contacted for more research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had your full genetic code (genome) sequenced as part of one of these specific studies: Incidental Genomics, Genetics Adviser, or GENCOV.
- You must have agreed at that time to be contacted about future research.
- You must be able to give your own consent to participate.
- You must be able to speak English, and have access to the internet and an electronic device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study helps parents understand genetic test results that show they carry a gene linked to cancer risk. Researchers will talk with you about what these results mean for your family's health and how to share this information with relatives.
This study collects and stores DNA samples and related health information from people of all ages. It helps researchers understand childhood diseases better and may support future discoveries and treatments.
This study tests a new online way to offer genetic testing and counseling for people concerned about hereditary cancer. It aims to make it easier and faster to access these services from home.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.